Key Points
- To examine the cellular mechanisms underlying endothelial dysfunction in type 2 diabetes and evaluate potential biomarkers for early detection and therapeutic intervention.
- Literature review exploring the cellular and physiological basis of endothelial impairment in diabetic vascular disease.
- Evaluation of endothelium-dependent vasodilator responses and circulating biomarkers as clinical tools for monitoring vascular health.
- Identifies endothelial dysfunction as an early, pivotal driver of accelerated atherogenesis, coronary artery disease, and peripheral vascular complications in diabetes.
- Determines that impaired endothelium-dependent vasodilation and blood flow responses represent crucial early indicators of cardiovascular morbidity.
- Highlights candidate vascular biomarkers as promising noninvasive indicators for detecting early endothelial impairment and developing targeted treatments.
Structured PICO
PPopulationPatients with type 2 diabetes
This review highlights endothelial dysfunction as an early indicator of cardiovascular disease in type 2 diabetes and explores its cellular basis to identify new therapeutic targets and biomarkers.